login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INSMED INC (INSM) Stock News
USA
- NASDAQ:INSM -
US4576693075
-
Common Stock
201.62
USD
+4.22 (+2.14%)
Last: 11/18/2025, 6:34:34 PM
202.5
USD
+0.88 (+0.44%)
After Hours:
11/18/2025, 6:34:34 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INSM Latest News, Press Relases and Analysis
All
Press Releases
8 hours ago - By: Benzinga
Peering Into Insmed Inc's Recent Short Interest
9 hours ago - By: Insmed Incorporated
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
9 hours ago - By: Insmed Incorporated
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
4 days ago - By: Benzinga
- Mentions:
STUB
APP
AMZN
MSFT
...
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves
6 days ago - By: Insmed Incorporated
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good
8 days ago - By: The Motley Fool
- Mentions:
AMSC
KTOS
STRL
TSEM
This Investor Sold $1.9 Million in AMSC Stock Ahead of 35% Post-Earnings Crash
9 days ago - By: The Motley Fool
- Mentions:
GSAT
KTOS
STRL
AMSC
...
Essex Investment Buys $7.1 Million Globalstar Stake as Revenue Hits Record High
14 days ago - By: Insmed Incorporated
Insmed To Present at November and December 2025 Investor Conferences
19 days ago - By: Zacks Investment Research
- Mentions:
ALKS
HOWL
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake
20 days ago - By: Investor's Business Daily
- Mentions:
ARGX
UTHR
LQDA
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports
20 days ago - By: Insmed Incorporated
Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
20 days ago - By: Zacks Investment Research
Gear Up for Insmed (INSM) Q3 Earnings: Wall Street Estimates for Key Metrics
a month ago - By: Insmed Incorporated
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
a month ago - By: Zacks Investment Research
Analysts Estimate Insmed (INSM) to Report a Decline in Earnings: What to Look Out for
a month ago - By: Insmed Incorporated
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
a month ago - By: Insmed Incorporated
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
a month ago - By: Insmed Incorporated
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
2 months ago - By: Zacks Investment Research
- Mentions:
UTHR
LQDA
Is IPF the Next Big Market Opportunity for United Therapeutics?
2 months ago - By: Insmed Incorporated
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
2 months ago - By: Zacks Investment Research
- Mentions:
MSFT
PM
AMZN
STX
...
Top Analyst Reports for Microsoft, Amazon.com & Philip Morris
2 months ago - By: Insmed Incorporated
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3 months ago - By: Zacks Investment Research
- Mentions:
UTHR
LQDA
UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals
Please enable JavaScript to continue using this application.